Ravi Singh

Ravi Singh


Research Outline

Although there has been much progress made in the field of novel antithrombotic treatments in the last two decades, it is known that the current therapies are severely deficient, particularly in terms of toxicity, and the major risk of bleeding. My research aims to use computational modelling and synthetic chemistry to help design inhibitors against a novel target. The analogues synthesized are tested in a chromogenic assay, which is ran alongside colleagues at the Leeds Institute of Cardiology and Metabolic Medicine (LICAMM) based here in the University of Leeds.

August 2018: Invited to speak at VICEPHEC18 held at the University of Sheffield and received the Royal Society of Chemistry Tertiary Education Group Bursary Award

August 2018: Received Associate Fellow of the Higher Education Academy (AFHEA) status for work on combining PhD research with Undergraduate Teaching Laboratories

June 2017: Poster Prize Winner (1st) at the School of Chemistry Postgraduate Conference in Leeds

December 2015: Graduated with MChem and BSc (Hons.) from the University of Leeds in Medicinal Chemistry

October 2015: Began PhD with Dr Richard Foster (School of Chemistry, University of Leeds). Co-supervised by Professors Colin Fishwick (School of Chemistry, University of Leeds), Robert Ariens (LICAMM, University of Leeds) and Helen Phillipou (LICAMM, University of Leeds)

Research interests

  • Medicinal Chemistry
  • Chemical Biology
  • Organic Synthesis
  • Chemical Education


  • AFHEA, University of Leeds
  • MChem, University of Leeds
  • BSc, Universty of Leeds

Research groups and institutes

  • Chemical Biology and Medicinal Chemistry